OSA
Price:
$0.47
Market Cap:
$8.18M
ProSomnus, Inc. manufactures precision oral appliance therapy devices for the treatment of obstructive sleep apnea (OSA). The company was founded in 2016 and is based in Pleasanton, California.
Industry
Medical - Devices
IPO Date
2021-07-28
Stock Exchange
NASDAQ
Ticker
OSA
According to ProSomnus, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.32. This represents a change of 243.25% compared to the average of -0.09 of the last 4 quarters.
The mean historical PE Ratio of ProSomnus, Inc. over the last ten years is -3.85. The current -0.32 PE Ratio has changed 720.01% with respect to the historical average. Over the past ten years (40 quarters), OSA's PE Ratio was at its highest in in the June 2023 quarter at 13.75. The PE Ratio was at its lowest in in the June 2021 quarter at -49.51.
Average
-3.85
Median
-3.59
Minimum
-25.06
Maximum
16.86
Discovering the peaks and valleys of ProSomnus, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 16.86
Minimum Annual Increase = -358.27%
Minimum Annual PE Ratio = -25.06
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -0.66 | -103.90% |
| 2022 | 16.86 | -358.27% |
| 2021 | -6.53 | -73.95% |
The current PE Ratio of ProSomnus, Inc. (OSA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.22
5-year avg
-3.85
10-year avg
-3.85
ProSomnus, Inc.’s PE Ratio is greater than Neoleukin Therapeutics, Inc. (-0.65), less than Biora Therapeutics, Inc. (-0.07), less than Turnstone Biologics Corp. (-0.17), greater than Tvardi Therapeutics, Inc. (-2.81), greater than NeuroMetrix, Inc. (-1.97), greater than COSCIENS Biopharma Inc. (-0.34), less than Omega Therapeutics, Inc. (-0.24), less than Holdco Nuvo Group D.G Ltd. Ordinary Shares (-0.10), less than SunLink Health Systems, Inc. (4.55), less than Centogene N.V. (-0.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.65 | $8.20M | |
| -0.07 | $994.99K | |
| -0.17 | $8.21M | |
| -2.81 | $39.21M | |
| -1.97 | $9.43M | |
| -0.34 | $6.43M | |
| -0.24 | $7.90M | |
| -0.10 | $5.65M | |
| 4.55 | $7.85M | |
| -0.22 | $9.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProSomnus, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProSomnus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ProSomnus, Inc.'s PE Ratio?
How is the PE Ratio calculated for ProSomnus, Inc. (OSA)?
What is the highest PE Ratio for ProSomnus, Inc. (OSA)?
What is the 3-year average PE Ratio for ProSomnus, Inc. (OSA)?
What is the 5-year average PE Ratio for ProSomnus, Inc. (OSA)?
How does the current PE Ratio for ProSomnus, Inc. (OSA) compare to its historical average?